ArticleInternational journal of molecular sciences2025

Functional Analysis of the PI3K/AKT/mTOR Pathway Inhibitor, Gedatolisib, Plus Fulvestrant with and Without Palbociclib in Breast Cancer Models.

Aaron Broege et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.